Shisuo Du1, Virginia Lockamy1, Lin Zhou2, Christine Xue1, Justin LeBlanc1, Shonna Glenn3, Gaurav Shukla1, Yan Yu1, Adam P Dicker1, Dennis B Leeper1, You Lu2, Bo Lu4. 1. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. 2. Department of Thoracic Oncology, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 3. Xstrahl, Inc, Suwanee, Georgia. 4. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: bo.lu@jefferson.edu.
Abstract
PURPOSE: To implement clinical stereotactic body radiation therapy (SBRT) using a small animal radiation research platform (SARRP) in a genetically engineered mouse model of lung cancer. METHODS AND MATERIALS: A murine model of multinodular Kras-driven spontaneous lung tumors was used for this study. High-resolution cone beam computed tomography (CBCT) imaging was used to identify and target peripheral tumor nodules, whereas off-target lung nodules in the contralateral lung were used as a nonirradiated control. CBCT imaging helps localize tumors, facilitate high-precision irradiation, and monitor tumor growth. SBRT planning, prescription dose, and dose limits to normal tissue followed the guidelines set by RTOG protocols. Pathologic changes in the irradiated tumors were investigated using immunohistochemistry. RESULTS: The image guided radiation delivery using the SARRP system effectively localized and treated lung cancer with precision in a genetically engineered mouse model of lung cancer. Immunohistochemical data confirmed the precise delivery of SBRT to the targeted lung nodules. The 60 Gy delivered in 3 weekly fractions markedly reduced the proliferation index, Ki-67, and increased apoptosis per staining for cleaved caspase-3 in irradiated lung nodules. CONCLUSIONS: It is feasible to use the SARRP platform to perform dosimetric planning and delivery of SBRT in mice with lung cancer. This allows for preclinical studies that provide a rationale for clinical trials involving SBRT, especially when combined with immunotherapeutics.
PURPOSE: To implement clinical stereotactic body radiation therapy (SBRT) using a small animal radiation research platform (SARRP) in a genetically engineered mouse model of lung cancer. METHODS AND MATERIALS: A murine model of multinodular Kras-driven spontaneous lung tumors was used for this study. High-resolution cone beam computed tomography (CBCT) imaging was used to identify and target peripheral tumor nodules, whereas off-target lung nodules in the contralateral lung were used as a nonirradiated control. CBCT imaging helps localize tumors, facilitate high-precision irradiation, and monitor tumor growth. SBRT planning, prescription dose, and dose limits to normal tissue followed the guidelines set by RTOG protocols. Pathologic changes in the irradiated tumors were investigated using immunohistochemistry. RESULTS: The image guided radiation delivery using the SARRP system effectively localized and treated lung cancer with precision in a genetically engineered mouse model of lung cancer. Immunohistochemical data confirmed the precise delivery of SBRT to the targeted lung nodules. The 60 Gy delivered in 3 weekly fractions markedly reduced the proliferation index, Ki-67, and increased apoptosis per staining for cleaved caspase-3 in irradiated lung nodules. CONCLUSIONS: It is feasible to use the SARRP platform to perform dosimetric planning and delivery of SBRT in mice with lung cancer. This allows for preclinical studies that provide a rationale for clinical trials involving SBRT, especially when combined with immunotherapeutics.
Authors: Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Edward E Graves; Hu Zhou; Raja Chatterjee; Paul J Keall; Sanjiv Sam Gambhir; Christopher H Contag; Arthur L Boyer Journal: Med Phys Date: 2007-11 Impact factor: 4.071
Authors: Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth Journal: Lancet Oncol Date: 2015-05-13 Impact factor: 41.316
Authors: Jean-Pierre Bissonnette; Thomas G Purdie; Jane A Higgins; Winnie Li; Andrea Bezjak Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-25 Impact factor: 7.038
Authors: John Wong; Elwood Armour; Peter Kazanzides; Iulian Iordachita; Erik Tryggestad; Hua Deng; Mohammad Matinfar; Christopher Kennedy; Zejian Liu; Timothy Chan; Owen Gray; Frank Verhaegen; Todd McNutt; Eric Ford; Theodore L DeWeese Journal: Int J Radiat Oncol Biol Phys Date: 2008-08-01 Impact factor: 7.038
Authors: Sinisa Stanic; Rebecca Paulus; Robert D Timmerman; Jeff M Michalski; Robert B Barriger; Andrea Bezjak; Gregory M M Videtic; Jeffrey Bradley Journal: Int J Radiat Oncol Biol Phys Date: 2014-04-01 Impact factor: 7.038
Authors: Peter M K Westcott; Kyle D Halliwill; Minh D To; Mamunur Rashid; Alistair G Rust; Thomas M Keane; Reyno Delrosario; Kuang-Yu Jen; Kay E Gurley; Christopher J Kemp; Erik Fredlund; David A Quigley; David J Adams; Allan Balmain Journal: Nature Date: 2014-11-02 Impact factor: 49.962
Authors: Grit S Herter-Sprie; Houari Korideck; Camilla L Christensen; Jan M Herter; Kevin Rhee; Ross I Berbeco; David G Bennett; Esra A Akbay; David Kozono; Raymond H Mak; G Mike Makrigiorgos; Alec C Kimmelman; Kwok-Kin Wong Journal: Nat Commun Date: 2014-12-18 Impact factor: 14.919
Authors: Tsuicheng D Chiu; Tatsuya J Arai; James Campbell Iii; Steve B Jiang; Ralph P Mason; Strahinja Stojadinovic Journal: PLoS One Date: 2018-05-30 Impact factor: 3.240
Authors: Annaïg Bertho; Morgane Dos Santos; Sarah Braga-Cohen; Valérie Buard; Vincent Paget; Olivier Guipaud; Georges Tarlet; Fabien Milliat; Agnès François Journal: Front Med (Lausanne) Date: 2021-12-24
Authors: Shisuo Du; Neal McCall; Kyewon Park; Qing Guan; Paolo Fontina; Adam Ertel; Tingting Zhan; Adam P Dicker; Bo Lu Journal: Oncoimmunology Date: 2018-01-29 Impact factor: 8.110